Kratos Receives Single Award $93 Million Contract for High Performance Unmanned Aerial Drone Systems
Jan 02, 2018 12:00 pm UTC| Business
SAN DIEGO, Jan. 02, 2018 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Composite Engineering, Inc., subsidiary located in Roseville,...
Brookfield Closes Inaugural Infrastructure Debt Fund
Jan 02, 2018 12:00 pm UTC| Business
BROOKFIELD, NEWS, Jan. 02, 2018 -- Brookfield Asset Management Inc. (“Brookfield”) (NYSE:BAM) (TSX:BAM.A) (Euronext:BAMA) announced today that it held the final close on the Brookfield Infrastructure Debt Fund (“BID” or...
Veru Reports Fiscal 2017 Fourth-Quarter, Full-Year Financial Results
Jan 02, 2018 12:00 pm UTC| Business
-- Fiscal 2017 Marked by Actions to Advance Drug Pipeline; First New Drug Application (NDA) on Track for Submission in First Half of 2018; Three Additional NDAs Expected to be Filed: Two in 2019 and One in 2020 -- ...
Jan 02, 2018 12:00 pm UTC| Business
CARMIEL, Israel, Jan. 02, 2018 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), announced today interim data from the first 14 patients that completed, to date, the Company’s phase II clinical trial of...
Sandy Spring Bancorp, Inc. Completes Acquisition of WashingtonFirst Bankshares, Inc.
Jan 02, 2018 12:00 pm UTC| Business
OLNEY, Md., Jan. 02, 2018 -- Sandy Spring Bancorp, Inc. (NASDAQ:SASR) (“Sandy Spring”) announced today that it completed the acquisition of WashingtonFirst Bankshares, Inc. (“WashingtonFirst”), effective January 1,...
Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018
Jan 02, 2018 12:00 pm UTC| Business
RANCHO CORDOVA, Calif., Jan. 02, 2018 -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Chris Xu,...
G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
Jan 02, 2018 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a company...